Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...] …
Although the bulk of recent 340B-related legislative action has occurred in statehouses across the country, 340B advocates and stakeholders are [...] …
Rhode Island could soon become the next state to pass legislation with 340B contract pharmacy protections and reporting requirements, as [...] …
A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
A U.K.-based drugmaker recently asked a federal court to strike down Nebraska’s contract pharmacy access law, making it the latest [...] …
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …